A comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) of anthranilamide derivatives that are multidrug resistance modulators

被引:29
作者
Labrie, Philippe
Maddaford, Shawn P.
Fortin, Sebastien
Rakhit, Suman
Kotra, Lakshmi P.
Gaudreault, Rene C.
机构
[1] Univ Laval, Fac Pharm, Quebec City, PQ G1K 7P4, Canada
[2] Hop St Francois Assise, Unite Biotechnol & Bioingn, Quebec City, PQ G1L 3L5, Canada
[3] NeurAxon Inc, MaRS Ctr, Toronto, ON M5G 1L7, Canada
[4] Univ Toronto, Mol Design Informat Technol Ctr MDIT, Leslie Dan Fac Pharm, Toronto, ON M5S 2S2, Canada
[5] Univ Toronto, Hlth Network, Ctr Mol Deisgn & Preformulat, Toronto Gen Res Inst, Toronto, ON M5G 1L7, Canada
关键词
D O I
10.1021/jm060239b
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In a continuing effort to develop potent and selective modulators of P-glycoprotein (P-gp) activity overcoming the chemoresistance acquired by tumor cells during cancer chemotherapy, we developed 3D quantitative structure-activity relationship (3D QSAR) models using CoMFA and CoMSIA analyses. This study correlates the P-glycoprotein inhibitory activities of 49 structurally related anthranilamide derivatives to several physicochemical parameters representing steric, electrostatic, acceptor, donor, and hydrophobic fields. Both CoMFA and CoMSIA models using three different alignment conformations gave good internal predictions, and their cross-validated r(2) values are between 0.503 and 0.644. These most comprehensive CoMFA and CoMSIA models are useful in understanding the structure-activity relationships of anthranilamide derivatives as well as aid in the design of novel derivatives with enhanced modulation of P-gp activity.
引用
收藏
页码:7646 / 7660
页数:15
相关论文
共 60 条
[21]  
HYAFIL F, 1993, CANCER RES, V53, P4595
[22]   COMPASS - PREDICTING BIOLOGICAL-ACTIVITIES FROM MOLECULAR-SURFACE PROPERTIES - PERFORMANCE COMPARISONS ON A STEROID BENCHMARK [J].
JAIN, AN ;
KOILE, K ;
CHAPMAN, D .
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (15) :2315-2327
[23]   SURFACE GLYCOPROTEIN MODULATING DRUG PERMEABILITY IN CHINESE-HAMSTER OVARY CELL MUTANTS [J].
JULIANO, RL ;
LING, V .
BIOCHIMICA ET BIOPHYSICA ACTA, 1976, 455 (01) :152-162
[24]  
Klebe G, 1998, QSAR THR DIM QUAN ST, V3, P87
[25]   THE USE OF COMPOSITE CRYSTAL-FIELD ENVIRONMENTS IN MOLECULAR RECOGNITION AND THE DE-NOVO DESIGN OF PROTEIN LIGANDS [J].
KLEBE, G .
JOURNAL OF MOLECULAR BIOLOGY, 1994, 237 (02) :212-235
[26]   Three-dimensional quantitative similarity-activity relationships (3D QSiAR) from SEAL similarity matrices [J].
Kubinyi, H ;
Hamprecht, FA ;
Mietzner, T .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (14) :2553-2564
[27]   The molecular interaction of the high affinity reversal agent XR9576 with P-glycoprotein [J].
Martin, C ;
Berridge, G ;
Mistry, P ;
Higgins, C ;
Charlton, P ;
Callaghan, R .
BRITISH JOURNAL OF PHARMACOLOGY, 1999, 128 (02) :403-411
[28]   A FAST NEW APPROACH TO PHARMACOPHORE MAPPING AND ITS APPLICATION TO DOPAMINERGIC AND BENZODIAZEPINE AGONISTS [J].
MARTIN, YC ;
BURES, MG ;
DANAHER, EA ;
DELAZZER, J ;
LICO, I ;
PAVLIK, PA .
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 1993, 7 (01) :83-102
[29]   P-GLYCOPROTEIN EXPRESSION IN MALIGNANT-LYMPHOMA AND REVERSAL OF CLINICAL DRUG-RESISTANCE WITH CHEMOTHERAPY PLUS HIGH-DOSE VERAPAMIL [J].
MILLER, TP ;
GROGAN, TM ;
DALTON, WS ;
SPIER, CM ;
SCHEPER, RJ ;
SALMON, SE .
JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (01) :17-24
[30]  
Mistry P, 2001, CANCER RES, V61, P749